EFTA00677036.pdf

From: Brad Wechs > To: Paul Barrett CC: Barrett Team , Jeffrey Epstein <jeevacationgginail.com> Subject: Re: Healthcar Date: Mon, 13 Jul 2015 14:39:36 +0000 Hi paul-if you cld copy Jeffrey on these ideas as well I'd appreciate it, since I like to get his input. Thx, b Sent from my Verizon Wireless BlackBerry From: "Barrett, Paul S" Date: Thu, 9 Jul 2015 18:46:15 +0000 To: 'Brad Wechsle?<1 Cc: 'Richard Joslin' Barrett Team< ›; Nelson, Justin D Subject: Healthcare Brad We would also like to build a position in healthcare. The drug pipelines, the demographics, the expanded health insurance laws, the M&A environment and valuations should all continue to support the sector. We would like to begin with a portfolio of 3 stocks listed below. The size recommendations we make are based off a $10MM portfolio. $1MM spread across three names: Name Ticker Rating Target AKORN INC AKRX OW 58.00 ABBVIE INC ABBV OW 75.00 BRISTOL-MYERS SQUIBB CO BMY OW 75.00 Paul Paul Barrett I Managing Director I Global Investment Opportunities Group I J.P. Morgan Securities LLC I J.P. Morgan Private Bank I J.P. Morgan Chase Bank N.A. 320 Park Avenue, 14th Floor, New York, NY 10022 I T: NOT AN OFFICIAL CONFIRMATION: For informational purposes only. This report does not represent an official account of the holdings, balances, or transactions made in your account and is being provided at your request. Please refer to your monthly account statement for the official record of all of your account activities. For question, please call your .I.P. Morgan representative. In discussion of options and other strategies, results and risks are based solely on hypothetical examples cited; actual results and risks will vary depending on specific circumstances. Investors are urged to consider carefully whether option or option-related products in general, as well as the products or strategies discussed herein are suitable to their needs. In actual transactions, the client's counterparty for OTC derivatives applications is JPMorgan Chase Bank, N.A., and affiliates. For a copy of the "Characteristics and Risks of Standardized Options" booklet, please contact your JPMorgan Advisor. This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at http://www.jpmorgan.corapages/disclosures/email. EFTA00677036 This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at http://wwwj morgan.corn/pages/disclosures/email EFTA00677037